Publications by authors named "Andreea Temelie"
Article Synopsis
- Long-acting injectable antipsychotics (LAIAs) are believed to improve clinical outcomes for adults with psychiatric disorders, but research on their effectiveness in children is limited.
- This study evaluated pediatric patients under 18 who started LAIAs during an acute psychiatric hospitalization, comparing their psychiatric admissions and emergency service visits one year before and one year after starting treatment.
- Results showed a decrease in psychiatric admissions (from 47 to 38), psychiatric emergency service visits (from 24 to 16), and total days hospitalized (from 1040 to 774), suggesting that LAIAs may also have positive effects in pediatric patients.
Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders.
J Child Adolesc Psychopharmacol
August 2024
There are currently no long-acting injectable antipsychotics (LAIAs) that are approved by the Food and Drug Administration for use in child and adolescent patients, however these agents are used off-label for the treatment of various psychiatric disorders. This study aims to describe the initiation and maintenance dosing strategies of LAIAs in child and adolescent psychiatry inpatients. This was a single-site retrospective chart review of patients less than 18 years of age initiated on an LAIA during an acute psychiatric hospitalization between October 1, 2015, and October 31, 2022.
View Article and Find Full Text PDFObjectives: The goal of this quality improvement project (QIP) was to increase awareness of the serious medical consequences of clozapine-associated constipation to front line nursing staff and patients with schizophrenia.
Methods: The QIP was developed iteratively by psychiatric nurses, psychiatrists and pharmacists with input from patients. The processes involved a literature review, development of educational materials for staff and patients, and the creation of a daily bowel movements log (BML).